Recently, Wu et al. (19) investigated the effect of risperidone monotherapy on cognitive impairment in drug-naïve first-episode of psychosis patients (DNFE) and whether BDNF levels were correlated to improvement of cognition. This evidence concerns the gene BDNF and Cognitive impairment.